KIDD BRIAN F 4
4 · NATIONAL HEALTHCARE CORP · Filed Mar 16, 2026
Research Summary
AI-generated summary of this filing
National Healthcare (NHC) SVP/CFO Brian Kidd Exercises Stock Options
What Happened
Brian F. Kidd, Senior Vice President and Chief Financial Officer of National Healthcare Corp (NHC), exercised 1,853 stock options on March 12, 2026. The exercise price was $53.94 per share, totaling $99,951. The filing also shows a corresponding derivative disposition for 1,853 shares at $0, which reflects the conversion/reporting of the options rather than an open‑market sale.
Key Details
- Transaction date: 2026-03-12. Exercise price: $53.94 per share. Acquired shares: 1,853. Reported total = $99,951.
- Derivative disposition line: 1,853 shares @ $0 reported (reflects option conversion/reporting).
- Shares owned after the transaction: not disclosed on the Form 4 provided.
- Footnote: Options were granted under the 2020 Omnibus Equity Incentive Plan on March 8, 2023; grant and exercise are exempt from Section 16(b) under Rule 16b-3(d).
- Filing: Form 4 filed 2026-03-16 (filed within the SEC’s two business‑day deadline for a 2026-03-12 transaction).
Context
This was an exercise of previously granted options, not a purchase on the open market or a sale of shares. The $0 disposition entry is a reporting artifact tied to the derivative conversion and does not indicate proceeds from a sale. Exercises convert compensation-related options into shares and do not necessarily signal buying or selling intent in the market.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-03-12$53.94/sh+1,853$99,951→ 29,130 total - Exercise/Conversion
Option to Purchase Common Stock
[F1]2026-03-12−1,853→ 4,147 totalExercise: $53.94From: 2024-03-08Exp: 2028-03-08→ Common Stock (6,000 underlying)
- 8,000
Option to Purchase Common Stock
Exercise: $94.10From: 2025-03-05Exp: 2029-03-05→ Common Stock (8,000 underlying) - 9,500
Option to Purchase Common Stock
Exercise: $90.62From: 2026-02-24Exp: 2030-02-24→ Common Stock (9,500 underlying) - 14,000
Option to Purchase Common Stock
Exercise: $157.13From: 2027-02-23Exp: 2031-02-23→ Common Stock (14,000 underlying)
Footnotes (1)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).